title: Interferon-alpha in combination with corticosteroids improves systemic mast cell disease.
authors.forename: E
authors.initials: E
authors.lastname: Delaporte
authors.forename: E
authors.initials: E
authors.lastname: Piérard
authors.forename: B G
authors.initials: BG
authors.lastname: Wolthers
authors.forename: P
authors.initials: P
authors.lastname: Desreumaux
authors.forename: A
authors.initials: A
authors.lastname: Janin
authors.forename: A
authors.initials: A
authors.lastname: Cortot
authors.forename: F
authors.initials: F
authors.lastname: Piette
authors.forename: H
authors.initials: H
authors.lastname: Bergoend
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D014582:Urticaria Pigmentosa / Q000473:pathology / Q000628:therapy*
chemical_list: D016898:Interferon-alpha; D011239:Prednisolone